Effect of root bark extract of Berberis vulgaris L. on Leishmania major on BALB/c mice

被引:0
作者
Alireza Salehabadi
Mahdi Karamian
Motevalli Haghi Farzad
Mohammad Hasan Namaei
机构
[1] Birjand University of Medical Sciences,Department of Microbiology
[2] Birjand University of Medical Sciences,Birjand Hepatitis Research Center
[3] Mazandaran University of Medical Sciences,Faculty of Health
来源
Parasitology Research | 2014年 / 113卷
关键词
Visceral Leishmaniasis; Leishmaniasis; Cutaneous Leishmaniasis; Root Bark; Antileishmanial Activity;
D O I
暂无
中图分类号
学科分类号
摘要
Leishmaniasis is one of the most important diseases transmitted by arthropod. This disease is present in 88 countries. Approximately 400 million people are at risk, and 12 million are involved. We aimed to examine the application of ethanolic extract of the root bark of Berberis vulgaris L. for treatment of mice infected with cutaneous leishmaniasis. At first, 40 BALB/c mice were infected to Leishmania major promastigotes and were divided in two groups A and B. Then, each of A and B groups were divided to two subgroups. Mice from subgroup A1 were treated with 10 % root bark alcoholic extract, and mice from subgroup A2 were treated with only alcohol (control). Mice from subgroup B1 were treated with 20 % root bark alcoholic extract, and mice from subgroup B2 were treated with only alcohol (control). The 90 % recovery was found in the mice treated with 20 % root bark extract, and 55 % recovery was found with 10 % root bark extract, but in the control group, 0 % recovery was found. The results of our study showed that the lotion of root bark extract has good suppression effects on parasites. Therefore, it might be a pro for developing new antileishmanial drugs.
引用
收藏
页码:953 / 957
页数:4
相关论文
共 76 条
[1]  
Alavinia SM(2009)Some epidemiological aspects of cutaneous leishmaniasis in Northern Khorasan Province, Iran J Arthropod-Borne Dis 3 50-54
[2]  
Arzamani K(2007)The berberis story: Pak J Pharm Sci 20 83-92
[3]  
Reihani MH(2007) L. in therapeutics J Infect Dis 196 591-598
[4]  
Jafari J(2008)Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis Acta Med Iran 46 191-196
[5]  
Arayne MS(2006)Evaluation of miltefosine against Iran J Parasitol 1 39-42
[6]  
Sultana N(2007) (MRHO/IR/75/ER): in vitro and in vivo studies Parasitol Res 101 1319-1322
[7]  
Bahadur SS(2007)Treatment of cutaneous leishmaniasis in murine model by alcoholic extract of J Sch Publ Health Inst Publ Health Res 5 35-42
[8]  
Bhattacharya SK(2012)Glucantime-resistant Parasitol Res 111 2115-2121
[9]  
Sinha PK(2007) isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs Med J Aust 186 315-317
[10]  
Sundar S(2008)The effect of an alcoholic extract of Parasitol Res 103 1273-1278